Back to Search Start Over

Extracellular vesicle-orchestrated crosstalk between cancer-associated fibroblasts and tumors

Authors :
Guiquan Zhu
Chuanshi He
Linlin Wang
Ling Li
Source :
Translational Oncology, Vol 14, Iss 12, Pp 101231-(2021), Translational Oncology
Publication Year :
2021
Publisher :
Elsevier, 2021.

Abstract

Highlights • EVs mediate the interaction between tumor and stromal cells in the TME. • Tumors mediate CAF-like activation of stromal cells through EVs. • CAF-derived EVs promote tumor proliferation, metastasis and therapeutic resistance.<br />Communication networks in the tumor microenvironment (TME) play a crucial role in tumor progression. Cancer-associated fibroblasts (CAFs) are among the most abundant stromal cells in the TME. Bidirectional signal transduction between cancer cells and CAFs within the TME is important for cancer development and treatment responsiveness. Extracellular vesicles (EVs) carrying proteins, miRNAs, and other biomolecules are secreted into the extracellular matrix (ECM), which has been demonstrated to be an important communication medium between tumors and CAFs. Tumors regulate the activation of CAFs by secreting EVs. Conversely, CAFs can also affect tumor proliferation, metastasis, and therapeutic resistance through EVs. Here, we will classify EV cargoes and discuss the role of EV-mediated interactions between CAFs and tumors, reviewing current knowledge in combination with our confirmed results.

Subjects

Subjects :
GAS6, growth retardant specific protein 6
Cancer Research
ER, estrogen receptor
SACC, salivary adenoid cystic carcinoma
TNFR1, tumor necrosis factor receptor 1
HPLF, human periodontal ligament fibroblast
MSC, mesenchymal stem cell
Review
FGF5, fibroblast growth factor 5
HNSCC, head and neck squamous cell carcinoma
NID1, Nidogen 1
Signal transduction
Metastasis
lncRNA, long non-coding RNA
Extracellular matrix
EZH2, enhancer of zeste homolog 2
HUVEC, human umbilical vein endothelial cell
GDF15, growth differentiation factor 15
RC254-282
Treg, cell regulatory T cell
ncRNA, non-coding RNA
VASH1, vasohibin 1
CAV1, caveolin 1
LIF, leukemia inhibitory factor
PDGFRS, platelet-derived growth factor receptor
TME, tumor microenvironment
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
FAP, fibroblast activating protein
Extracellular vesicle
VEGF, vascular endothelial growth factor
ECM, extracellular matrix
MCC, Merkel cell carcinogenic
Oncology
Tumor microenvironment
CRC, colorectal cancer
MVB, multivesicular body
TP53InP1, TP53-induced nucleoprotein 1
CSCC, cervical squamous cell carcinoma
EMT, epithelial-mesenchymal transition
JAK, Janus kinase
Stromal cell
NGF, nerve growth factor
PRSC, prostatic stromal cell
Biology
TNBC, triple-negative breast cancer
CTGF, connective tissue growth factor
α-SMA, α-smooth muscle actin
CM, conditioned medium
EV, extracellular vesicle
medicine
OSCC, oral squamous cell carcinoma
FN, fibronectin
tTG, tissue transglutaminase
Cancer-associated fibroblasts
CAF, cancer-associated fibroblast
ILV, intracavinal vesicle
CCAL, colorectal cancer-associated lncRNA
HL, Hodgkin's lymphoma
medicine.disease
SRF, serum response factor
YAP1, YES-associated protein 1
CYR61, cysteine-rich angiogenesis inducer 61
PAF, paracancerous fibroblast
SNARE, soluble NSF-attachment protein receptor
Tumor progression
Cancer cell
Cancer research
Cancer-Associated Fibroblasts
CSD, CAV1 scaffolding domain
HGF, hepatocyte growth factor
HCC, hepatocellular carcinoma

Details

Language :
English
ISSN :
19365233
Volume :
14
Issue :
12
Database :
OpenAIRE
Journal :
Translational Oncology
Accession number :
edsair.doi.dedup.....fc5dbb220f9849b850d3378d75eced1b